John Nicosia

Company: Vasarya Therapeutics

Job title: Co-Founder & Chief Operating Officer

Seminars:

Decoding the Fibrotic Circuitry to Sharpen Discovery with Mechanistic Clarity & Context-Specific Targeting 11:00 am - 1:00 pm

As antifibrotic drug development evolves, a deeper understanding of the cellular architecture and communication networks that drive fibrosis is critical. This workshop explores fibroblast biology across indications, highlighting how tissue-specific and conserved mechanisms can better inform early target selection and derisk downstream development. This workshop will gather experts to discuss: Dissecting immune–fibroblast, epithelial–fibroblast, and vascular–fibroblast…Read more

day: Pre-Conference Day

Panel Discussion: What Does Good Look Like for Investors & Pharma? Defining Value & De-Risking Strategies to Attract Investment in Antifibrotics 2:00 pm

As competition and innovation grow across fibrosis indications, clarity on what makes a compelling therapeutic story is more essential than ever. This panel brings together experts to explore how to shape preclinical packages that spark commercial interest and secure partnerships. Key Discussion Points: What types of efficacy, durability, mechanism, safety, and translatability data do investors…Read more

day: Conference Day One